TP53 and breast carcinoma: Cai, J. Xia, J. Zou, Q. Wang, Q. Ma, R. Sun, H. Liao, L. Xu, D. Wang, and X. Guo, "The PI3K/mTOR Dual Inhibitor NVP-BEZ235 Stimulates Mutant p53 Degradation to Exert Anti-Tumor Effects on Triple-Negative Breast Cancer Cells," FEBS Open Bio 10, no. 4 (2020): 535-545, https://doi.org/10.1002/2211-5463.12806.